Corticosteroids are effective for treating IgA nephropathy but have important adverse effects. In this secondary analysis of the TESTING cohort, we generated a model to predict, for an individual patient, the probability that they will respond to corticosteroids.
Kidney International published a clinical update in Research Highlights on 20 Jan 2026.
The item focuses on A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy.
Review the original article for the full source wording and details.